Fusion PharmaceuticalsI Stock Forecast - Maximum Drawdown

FUSN Stock  USD 21.25  0.01  0.05%   
Fusion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Fusion PharmaceuticalsI stock prices and determine the direction of Fusion PharmaceuticalsInc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Fusion PharmaceuticalsI's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Fusion PharmaceuticalsI's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Fusion PharmaceuticalsI's systematic risk associated with finding meaningful patterns of Fusion PharmaceuticalsI fundamentals over time.
Check out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections.
  
As of the 19th of April 2024, Fixed Asset Turnover is likely to grow to 0.14, though Inventory Turnover is likely to grow to (6.52). . As of the 19th of April 2024, Common Stock Shares Outstanding is likely to drop to about 57.7 M. In addition to that, Net Loss is likely to grow to about (74.9 M).

Open Interest Against 2024-04-19 Fusion Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Fusion PharmaceuticalsI's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Fusion PharmaceuticalsI's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Fusion PharmaceuticalsI stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Fusion PharmaceuticalsI's open interest, investors have to compare it to Fusion PharmaceuticalsI's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Fusion PharmaceuticalsI is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Fusion. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Fusion PharmaceuticalsInc has current Maximum Drawdown of 0.
Most investors in Fusion PharmaceuticalsI cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Fusion PharmaceuticalsI's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Fusion PharmaceuticalsI's price structures and extracts relationships that further increase the generated results' accuracy.
Check Fusion PharmaceuticalsI VolatilityBacktest Fusion PharmaceuticalsIInformation Ratio  

Fusion PharmaceuticalsI Trading Date Momentum

On April 19 2024 Fusion PharmaceuticalsInc was traded for  21.25  at the closing time. The top price for the day was 21.30  and the lowest listed price was  21.20 . There was no trading activity during the period 0.0. Lack of trading volume on April 19, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.09% .
Compare Fusion PharmaceuticalsI to competition

Other Forecasting Options for Fusion PharmaceuticalsI

For every potential investor in Fusion, whether a beginner or expert, Fusion PharmaceuticalsI's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fusion. Basic forecasting techniques help filter out the noise by identifying Fusion PharmaceuticalsI's price trends.

View Fusion PharmaceuticalsI Related Equities

 Risk & Return  Correlation

Fusion PharmaceuticalsInc Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fusion PharmaceuticalsI's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fusion PharmaceuticalsI's current price.

Fusion PharmaceuticalsI Market Strength Events

Market strength indicators help investors to evaluate how Fusion PharmaceuticalsI stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion PharmaceuticalsI shares will generate the highest return on investment. By undertsting and applying Fusion PharmaceuticalsI stock market strength indicators, traders can identify Fusion PharmaceuticalsInc entry and exit signals to maximize returns.

Fusion PharmaceuticalsI Risk Indicators

The analysis of Fusion PharmaceuticalsI's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fusion PharmaceuticalsI's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Fusion PharmaceuticalsI Investors Sentiment

The influence of Fusion PharmaceuticalsI's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Fusion. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Fusion PharmaceuticalsI's public news can be used to forecast risks associated with an investment in Fusion. The trend in average sentiment can be used to explain how an investor holding Fusion can time the market purely based on public headlines and social activities around Fusion PharmaceuticalsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Fusion PharmaceuticalsI's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Fusion PharmaceuticalsI's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Fusion PharmaceuticalsI's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Fusion PharmaceuticalsI.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fusion PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fusion PharmaceuticalsI's short interest history, or implied volatility extrapolated from Fusion PharmaceuticalsI options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fusion PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fusion PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fusion Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fusion Pharmaceuticalsinc Stock:
Check out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Fusion Stock analysis

When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.45)
Revenue Per Share
0.032
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.25)
Return On Equity
(0.49)
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.